AstraZeneca (AZ) has been granted a global online license by Nanoform to access its STARMAP artificial intelligence (AI) technology to screen molecules. The agreement builds on several years of early-stage collaboration between both companies, as well as a completed technology evaluation partnership, including STARMAP.